The rise of Sildenafil initially drove a surge for the drug industry, but recent changes present a murky picture for those considering a stake. Off-patent alternatives are eating into revenue, and continued legal https://honeycufy774024.idblogz.com/41527126/the-blue-pill-and-pharma-a-precarious-bet